UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Applications of Metabolomics in Oncology: A Review

Clinical cancer research, 2009-01, Vol.15 (2), p.431-440

2009

Volltextzugriff (PDF)

Ligand-Based Targeting of Apoptosis in Cancer: The Potential of Recombinant Human Apoptosis Ligand 2/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (rhApo2L/TRAIL)

Journal of clinical oncology, 2008-07, Vol.26 (21), p.3621-3630

2008

Volltextzugriff (PDF)

Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer

Clinical cancer research, 2019-10, Vol.25 (19), p.5852-5858

2019

Volltextzugriff (PDF)

Role of Ubiquitin Ligases and the Proteasome in Oncogenesis: Novel Targets for Anticancer Therapies

Journal of clinical oncology, 2013-03, Vol.31 (9), p.1231-1238

2013

Volltextzugriff (PDF)

The changing landscape of phase I trials in oncology

Nature reviews. Clinical oncology, 2016-02, Vol.13 (2), p.106-117

2016

Volltextzugriff (PDF)

Interrogating open issues in cancer precision medicine with patient-derived xenografts

Nature reviews. Cancer, 2017-04, Vol.17 (4), p.254-268

2017

Volltextzugriff (PDF)

Sunitinib: From Rational Design to Clinical Efficacy

Journal of clinical oncology, 2007-03, Vol.25 (7), p.884-896

2007

Volltextzugriff (PDF)

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2

Journal of clinical oncology, 2010-02, Vol.28 (5), p.780-787

2010

Volltextzugriff (PDF)

Current methods in translational cancer research

Cancer and metastasis reviews, 2021-03, Vol.40 (1), p.7-30

2021

Volltextzugriff (PDF)

AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors

The oncologist (Dayton, Ohio), 2013-07, Vol.18 (7), p.819-820

2013

Volltextzugriff (PDF)

KRAS Mutations and Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer: Practical Application of Patient Selection

Journal of clinical oncology, 2009-03, Vol.27 (7), p.1130-1136

2009

Volltextzugriff (PDF)

Three-Dimensional Regeneration of Patient-Derived Intestinal Organoid Epithelium in a Physiodynamic Mucosal Interface-on-a-Chip

Micromachines (Basel), 2020-07, Vol.11 (7), p.663

2020

Volltextzugriff (PDF)

Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer

Journal of clinical oncology, 2010-06, Vol.28 (17), p.2839-2846

2010

Volltextzugriff (PDF)

Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment

The journal of clinical endocrinology and metabolism, 2020-01, Vol.105 (1), p.26-42

2020

Volltextzugriff (PDF)

A comparative cohort study of gastrointestinal oncology patients: Impact of a shift to telehealth on delivery of interprofessional cancer care

Journal of telemedicine and telecare, 2024-09, Vol.30 (7), p.1116-1122

2024

Volltextzugriff (PDF)

A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies

Clinical cancer research, 2010-02, Vol.16 (4), p.1256-1263

2010

Volltextzugriff (PDF)

Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling Mechanisms

Molecular cancer therapeutics, 2018-10, Vol.17 (10), p.2112-2122

2018

Volltextzugriff (PDF)

Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma

Molecular cancer therapeutics, 2019-02, Vol.18 (2), p.278-288

2019

Volltextzugriff (PDF)

A Multicenter Phase I Trial of PX-866, an Oral Irreversible Phosphatidylinositol 3-Kinase Inhibitor, in Patients with Advanced Solid Tumors

Clinical cancer research, 2012-08, Vol.18 (15), p.4173-4182

2012

Volltextzugriff (PDF)

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers

Journal of clinical oncology, 2008-05, Vol.26 (13), p.2139-2146

2008

Volltextzugriff (PDF)

Phase I Dose-Escalation Study of the Pan-HER Inhibitor, PF299804, in Patients with Advanced Malignant Solid Tumors

Clinical cancer research, 2011-03, Vol.17 (5), p.1131-1139

2011

Volltextzugriff (PDF)

Integrated Genomic Characterization of the Human Immunome in Cancer

Cancer research (Chicago, Ill.), 2020-11, Vol.80 (21), p.4854-4867

2020

Volltextzugriff (PDF)

Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents

Frontiers in oncology, 2016-07, Vol.6, p.152-152

2016

Volltextzugriff (PDF)

Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer

Cancer research (Chicago, Ill.), 2023-01, Vol.83 (1), p.59-73

2023

Volltextzugriff (PDF)

Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)

Journal of medicinal chemistry, 2012-05, Vol.55 (9), p.4101-4113

2012

Volltextzugriff (PDF)

1 – 25 von 342

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(332)
Mit Volltextzugriff
(310)

Publikationsform

Sprache

Englisch
(342)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical Applications of Metabolomics in Oncology: A Review

Ligand-Based Targeting of Apoptosis in Cancer: The Potential of Recombinant Human Apoptosis Ligand 2/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (rhApo2L/TRAIL)

Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer

Role of Ubiquitin Ligases and the Proteasome in Oncogenesis: Novel Targets for Anticancer Therapies

The changing landscape of phase I trials in oncology

Interrogating open issues in cancer precision medicine with patient-derived xenografts

Sunitinib: From Rational Design to Clinical Efficacy

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2

Current methods in translational cancer research

AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors

KRAS Mutations and Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer: Practical Application of Patient Selection

Three-Dimensional Regeneration of Patient-Derived Intestinal Organoid Epithelium in a Physiodynamic Mucosal Interface-on-a-Chip

Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer

Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment

A comparative cohort study of gastrointestinal oncology patients: Impact of a shift to telehealth on delivery of interprofessional cancer care

A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies

Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling Mechanisms

Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma

A Multicenter Phase I Trial of PX-866, an Oral Irreversible Phosphatidylinositol 3-Kinase Inhibitor, in Patients with Advanced Solid Tumors

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers

Phase I Dose-Escalation Study of the Pan-HER Inhibitor, PF299804, in Patients with Advanced Malignant Solid Tumors

Integrated Genomic Characterization of the Human Immunome in Cancer

Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents

Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer

Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)

Suchergebnisse filtern